NATHAN LINGLE: Open Payments
NPI 1649938945 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 31 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $225 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $196 |
| Electromed, Inc. | 8 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| ABBVIE INC. | 1 | $33 |
| 3B Medical, Inc. | 1 | $17 |
Products named: TRELEGY ELLIPTA, SMARTVEST, OFEV, GLASSIA, TEFLARO, LUNA, TEZSPIRE, BREZTRI.
Industry payments across MS — which companies pay providers there.
